Propel Bio Management »

Eiger Biopharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Eiger Biopharmaceuticals shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Eiger Biopharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eiger Biopharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eiger Biopharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $986k 4.4M 0.22

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Applied Therapeutics Comm (APLT)
Tscan Therapeutics Comm (TCRX)
Madrigal Pharmaceuticals Comm (MDGL)
Crinetics Pharmaceuticals In Comm (CRNX)
Fulcrum Therapeutics Comm (FULC)
Fidelity Inv Mmtrsy 1 680 Comm
Phathom Pharmaceuticals Comm (PHAT)
Day One Biopharmaceuticals I Comm (DAWN)
Ardelyx Comm (ARDX)
Athira Pharma Comm (ATHA)
Telesat Corp Comm (TSAT)
Simplify Enhanced Income Comm (HIGH)
Akero Therapeutics Comm (AKRO)
Vanguard Short-term Bond Comm (BSV)

View all positions for Propel Bio Management

Top funds holding Eiger Biopharmaceuticals

Propel Bio Management
683 Capital Management
Vanguard Group
Millennium Management
Two Sigma Securities
Bank of America Corporation
Tocqueville Asset Management
Charles Schwab Investment Management
Townsquare Capital
Dfpg Investments
Jane Street
Hrt Financial
Citadel Advisors
UBS Group
Advisor Group Holdings

View all funds holding Eiger Biopharmaceuticals